Compare SLDP & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLDP | AXGN |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | 230 | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 714.7M | 1.7B |
| IPO Year | N/A | 2013 |
| Metric | SLDP | AXGN |
|---|---|---|
| Price | $3.13 | $30.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $7.00 | ★ $37.63 |
| AVG Volume (30 Days) | ★ 3.2M | 815.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $13.88 | $19.81 |
| Revenue Next Year | $10.00 | $16.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $0.68 | $9.22 |
| 52 Week High | $8.86 | $36.00 |
| Indicator | SLDP | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 33.61 | 45.44 |
| Support Level | $2.94 | $30.42 |
| Resistance Level | $4.70 | $34.26 |
| Average True Range (ATR) | 0.19 | 1.46 |
| MACD | 0.03 | 0.19 |
| Stochastic Oscillator | 17.06 | 50.38 |
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.